Precision BioSciences Inc

Precision BioSciences Inc is an American clinical-stage gene editing company focused on developing novel therapeutic approaches. Its primary aim is to create transformative medicines across various disease areas, including oncology, genetic diseases, and infectious diseases. Operating in the US, it collaborates with partners globally to advance its gene-editing solutions. Operating within the biotechnology sector, Precision BioSciences Inc leverages its proprietary ARCUS genome editing platform. This technology underpins its development of innovative in vivo and ex vivo gene editing therapies, aiming to address significant unmet medical needs. Explore DTIL share prices and other stocks on eToro. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.